JUPITER-02 Phase III Global Study of Toripalimab at the Interim Analysis Met Pre-Specified Primary Endpoint of Progression-Free Survival in Recurrent or Metastatic Nasopharyngeal Carcinoma

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition